BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 30794281)

  • 1. Whole Exome Sequencing of Ulcerative Colitis-associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients.
    Yan P; Wang Y; Meng X; Yang H; Liu Z; Qian J; Zhou W; Li J
    Inflamm Bowel Dis; 2019 Jul; 25(8):1293-1301. PubMed ID: 30794281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of Genome Alterations in Crohn's Disease-Associated Colorectal Carcinogenesis.
    Hirsch D; Wangsa D; Zhu YJ; Hu Y; Edelman DC; Meltzer PS; Heselmeyer-Haddad K; Ott C; Kienle P; Galata C; Horisberger K; Ried T; Gaiser T
    Clin Cancer Res; 2018 Oct; 24(20):4997-5011. PubMed ID: 29967250
    [No Abstract]   [Full Text] [Related]  

  • 3. Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers.
    Robles AI; Traverso G; Zhang M; Roberts NJ; Khan MA; Joseph C; Lauwers GY; Selaru FM; Popoli M; Pittman ME; Ke X; Hruban RH; Meltzer SJ; Kinzler KW; Vogelstein B; Harris CC; Papadopoulos N
    Gastroenterology; 2016 Apr; 150(4):931-43. PubMed ID: 26764183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease.
    Yaeger R; Shah MA; Miller VA; Kelsen JR; Wang K; Heins ZJ; Ross JS; He Y; Sanford E; Yantiss RK; Balasubramanian S; Stephens PJ; Schultz N; Oren M; Tang L; Kelsen D
    Gastroenterology; 2016 Aug; 151(2):278-287.e6. PubMed ID: 27063727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Crohn's disease-associated colorectal carcinogenesis : TP53 mutations and copy number gains of chromosome arm 5p as (early) markers of tumor progression].
    Hirsch D; Gaiser T
    Pathologe; 2018 Dec; 39(Suppl 2):253-261. PubMed ID: 30229283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted sequencing-based analyses of candidate gene variants in ulcerative colitis-associated colorectal neoplasia.
    Chakrabarty S; Varghese VK; Sahu P; Jayaram P; Shivakumar BM; Pai CG; Satyamoorthy K
    Br J Cancer; 2017 Jun; 117(1):136-143. PubMed ID: 28524162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of ulcerative colitis-associated colorectal carcinomas.
    Hirsch D; Hardt J; Sauer C; Heselmeyer-Hadded K; Witt SH; Kienle P; Ried T; Gaiser T
    Mod Pathol; 2021 Jun; 34(6):1153-1166. PubMed ID: 33318582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole exome sequencing reveals intertumor heterogeneity and distinct genetic origins of sporadic synchronous colorectal cancer.
    Di J; Yang H; Jiang B; Wang Z; Ji J; Su X
    Int J Cancer; 2018 Mar; 142(5):927-939. PubMed ID: 29105743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic characterization of colitis-associated colorectal cancer.
    Kameyama H; Nagahashi M; Shimada Y; Tajima Y; Ichikawa H; Nakano M; Sakata J; Kobayashi T; Narayanan S; Takabe K; Wakai T
    World J Surg Oncol; 2018 Jul; 16(1):121. PubMed ID: 29966533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated Colorectal Cancer.
    Rajamäki K; Taira A; Katainen R; Välimäki N; Kuosmanen A; Plaketti RM; Seppälä TT; Ahtiainen M; Wirta EV; Vartiainen E; Sulo P; Ravantti J; Lehtipuro S; Granberg KJ; Nykter M; Tanskanen T; Ristimäki A; Koskensalo S; Renkonen-Sinisalo L; Lepistö A; Böhm J; Taipale J; Mecklin JP; Aavikko M; Palin K; Aaltonen LA
    Gastroenterology; 2021 Aug; 161(2):592-607. PubMed ID: 33930428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolutionary history of human colitis-associated colorectal cancer.
    Baker AM; Cross W; Curtius K; Al Bakir I; Choi CR; Davis HL; Temko D; Biswas S; Martinez P; Williams MJ; Lindsay JO; Feakins R; Vega R; Hayes SJ; Tomlinson IPM; McDonald SAC; Moorghen M; Silver A; East JE; Wright NA; Wang LM; Rodriguez-Justo M; Jansen M; Hart AL; Leedham SJ; Graham TA
    Gut; 2019 Jun; 68(6):985-995. PubMed ID: 29991641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Aberrant Alteration of Genome in Colorectal Cancer by Exome Sequencing.
    Liang Y; Jiang L; Zhong X; Hochwald SN; Wang Y; Huang L; Nie Q; Huang H; Xu JF
    Am J Med Sci; 2019 Nov; 358(5):340-349. PubMed ID: 31445671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic mutation profiles as molecular classifiers of ulcerative colitis-associated colorectal cancer.
    Mäki-Nevala S; Ukwattage S; Olkinuora A; Almusa H; Ahtiainen M; Ristimäki A; Seppälä T; Lepistö A; Mecklin JP; Peltomäki P
    Int J Cancer; 2021 Jun; 148(12):2997-3007. PubMed ID: 33521965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers.
    Alpert L; Yassan L; Poon R; Kadri S; Niu N; Patil SA; Mujacic I; Montes D; Galbo F; Wurst MN; Zhen CJ; Cohen RD; Rubin DT; Pekow JR; Weber CR; Xiao SY; Hart J; Segal J; Setia N
    Hum Pathol; 2019 Jul; 89():44-50. PubMed ID: 31054900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A specific genetic alteration on chromosome 6 in ulcerative colitis-associated colorectal cancers.
    Ezaki T; Watanabe M; Inoue N; Kanai T; Ogata H; Iwao Y; Ishii H; Hibi T
    Cancer Res; 2003 Jul; 63(13):3747-9. PubMed ID: 12839969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic ulcerative colitis and colorectal cancer.
    Rogler G
    Cancer Lett; 2014 Apr; 345(2):235-41. PubMed ID: 23941831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer.
    Carethers JM; Jung BH
    Gastroenterology; 2015 Oct; 149(5):1177-1190.e3. PubMed ID: 26216840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Positively and Negatively Selected Driver Gene Mutations Associated With Colorectal Cancer With Microsatellite Instability.
    Jonchere V; Marisa L; Greene M; Virouleau A; Buhard O; Bertrand R; Svrcek M; Cervera P; Goloudina A; Guillerm E; Coulet F; Landman S; Ratovomanana T; Job S; Ayadi M; Elarouci N; Armenoult L; Merabtene F; Dumont S; Parc Y; Lefèvre JH; André T; Fléjou JF; Guilloux A; Collura A; de Reyniès A; Duval A
    Cell Mol Gastroenterol Hepatol; 2018; 6(3):277-300. PubMed ID: 30116770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of TP53 loss and whole-genome doubling in early-onset colorectal cancer.
    Kim JE; Choi J; Sung CO; Hong YS; Kim SY; Lee H; Kim TW; Kim JI
    Exp Mol Med; 2021 Mar; 53(3):446-456. PubMed ID: 33753878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational Analysis Identifies Therapeutic Biomarkers in Inflammatory Bowel Disease-Associated Colorectal Cancers.
    Din S; Wong K; Mueller MF; Oniscu A; Hewinson J; Black CJ; Miller ML; Jiménez-Sánchez A; Rabbie R; Rashid M; Satsangi J; Adams DJ; Arends MJ
    Clin Cancer Res; 2018 Oct; 24(20):5133-5142. PubMed ID: 29950348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.